Effect of Individualized Training Versus Non-individualized Training to Improve Quality of Life of Sedentary Employees
NCT ID: NCT04832516
Last Updated: 2022-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
32 participants
INTERVENTIONAL
2021-04-07
2021-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examining Exercise, Health Coaching and Meditation for University Employees
NCT02936726
Physical Activity for Campus Employees
NCT01617499
Effects of Therapeutic Exercise on Quality of Life
NCT03529864
Investigating the Effectiveness of Exercise Coaching on the Physical Activity Behavior of Physically Inactive Employees.
NCT01759927
Increasing Workplace Physical Activity in Sedentary Office Workers
NCT01846013
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individualized exercise group (IND)
Group with adapted and personalized exercises (IND).The IND group will perform strength, aerobic or flexibility exercises depending on their needs observed during the first assessment.
Performing on their needs
The IND group will perform strength, aerobic or flexibility exercises depending on their needs observed during the first assessment.
Traditional exercise group (CLA)
Group with traditional exercise (CLA). The CLA group will perform exercises following WHO (World Health Organization) prescription.
Performing following WHO (World Health Organization)
The CLA group will perform exercises following WHO (World Health Organization) prescription
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Performing following WHO (World Health Organization)
The CLA group will perform exercises following WHO (World Health Organization) prescription
Performing on their needs
The IND group will perform strength, aerobic or flexibility exercises depending on their needs observed during the first assessment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Affiliate to health care organism
* Subject who gave their consent
Exclusion Criteria
* Pregnant women
* Cardiovascular trouble
* Subject who are not able to understand the proceeding of the study or to give their consent
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
CLEMENT FOSCHIA, MD
Role: PRINCIPAL_INVESTIGATOR
CHU St-Etienne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A03052-37
Identifier Type: OTHER
Identifier Source: secondary_id
20CH150
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.